Results 41 to 50 of about 7,402 (232)

The Role of Neutrophils in Oncolytic Orf Virus-Mediated Cancer Immunotherapy

open access: yesCells, 2022
Neutrophils are innate leukocytes with diverse effector functions that allow them to respond to pathogens rapidly. Accumulating evidence has highlighted these cells’ complex roles in the host’s response to viral infections and tumor progression ...
Jessica A. Minott   +5 more
doaj   +1 more source

CANCER GROWTH TREATMENT USING IMMUNE LINEAR QUADRATIC REGULATOR BASED ON CROW SEARCH OPTIMIZATION ALGORITHM [PDF]

open access: yesApplied Computer Science, 2021
The rapid and uncontrollable cell division that spreads to surrounding tissues medically termed as malignant neoplasm, cancer is one of the most common diseases worldwide.
Mohammed A. HUSSEIN   +2 more
doaj   +1 more source

Oncolytic Virotherapy and Microenvironment in Multiple Myeloma [PDF]

open access: yesInternational Journal of Molecular Sciences, 2021
Multiple myeloma (MM) is a hematologic malignancy characterized by the accumulation of bone marrow (BM) clonal plasma cells, which are strictly dependent on the microenvironment. Despite the improvement of MM survival with the use of new drugs, MM patients still relapse and become always refractory to the treatment.
Valentina Marchica   +3 more
openaire   +4 more sources

Tumor Restrictions to Oncolytic Virus

open access: yesBiomedicines, 2014
Oncolytic virotherapy has advanced since the days of its conception but therapeutic efficacy in the clinics does not seem to reach the same level as in animal models.
Markus Vähä-Koskela, Ari Hinkkanen
doaj   +1 more source

Oncolytic polio virotherapy of cancer [PDF]

open access: yesCancer, 2014
Recently, the century‐old idea of targeting cancer with viruses (oncolytic viruses) has come of age, and promise has been documented in early stage and several late‐stage clinical trials in a variety of cancers. Although originally prized for their direct tumor cytotoxicity (oncolytic virotherapy), recently, the proinflammatory and immunogenic effects ...
John H. Sampson   +12 more
openaire   +3 more sources

Oncolytic Virotherapy for Cancer: Clinical Experience [PDF]

open access: yesBiomedicines, 2021
Oncolytic viruses are a new class of therapeutics which are largely in the experimental stage, with just one virus approved by the FDA thus far. While the concept of oncolytic virotherapy is not new, advancements in the fields of molecular biology and virology have renewed the interest in using viruses as oncolytic agents.
Shyambabu Chaurasiya   +2 more
openaire   +4 more sources

Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions

open access: yesViruses, 2015
Oncolytic virotherapy for cancer is an innovative therapeutic option where the ability of a virus to promote cell lysis is harnessed and reprogrammed to selectively destroy cancer cells.
Janice Kim   +3 more
doaj   +1 more source

Oscillation thresholds via the novel MBR method with application to oncolytic virotherapy

open access: yesNonlinear Analysis, 2022
Oncolytic virotherapy is a therapy for the treatment of malignant tumours. In some undesirable cases, the injection of viral particles can lead to stationary oscillations, thus preventing the full destruction of the tumour mass.
Bruno Buonomo   +2 more
doaj   +1 more source

Nonlocal multiscale modelling of tumour-oncolytic viruses interactions within a heterogeneous fibrous/non-fibrous extracellular matrix [PDF]

open access: yesarXiv, 2021
In this study we investigate computationally tumour-oncolytic virus(OV) interactions that take place within a heterogeneous ExtraCellular Matrix (ECM). The ECM is viewed as a mixture of two constitutive phases, namely a fibre phase and a non-fibre phase.
arxiv  

Home - About - Disclaimer - Privacy